TIS 0.00% 0.0¢ tissue therapies limited

Or alternatively, using the methodology that says be acquired at...

  1. 10,914 Posts.
    lightbulb Created with Sketch. 3634
    Or alternatively, using the methodology that says be acquired at somewhere between 3 and 5 times sales (see post re competitor being acquired just prior to IPO) and
    using thymus number of sales @ $1.7B
    yields takeover value at between $5B-$8B
    divided by 170M shares to give
    Stock Price of between $29 - $47

    Clearly I must be dreaming!

    Using just 5% of the company target market size of $14B is still $700M with multiple at $2.1B - $3.5B

    Are we in that good a position???
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.